SCHEMBL7185736

SCHEMBL7185736

C=C(C)Oc1ccc(C(=O)C=Cc2ccc(OC(C)C)cc2OC(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TNFRSF1A P19438 1/20 0.53
CYP1A1 P04798 4/20 0.51
CYP1B1 Q16678 4/20 0.51
MAPT P10636 3/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
ALDH1A1 P00352 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
ABCG2 Q9UNQ0 2/20 0.45
MAOB P27338 1/20 0.44
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
PTPN1 P18031 4/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185731 1.00 TNFRSF1A (0.53) TNFRSF1ACYP1A1CYP1B1MAPTLMNA
SCHEMBL7183730 0.91 ABCG2 (0.54) TNFRSF1ACYP1A1CYP1B1MAPTLMNA
SCHEMBL7183724 0.91 ABCG2 (0.54) TNFRSF1ACYP1A1CYP1B1MAPTLMNA
SCHEMBL7191738 0.87 PTPN1 (0.46) TNFRSF1ACYP1A1CYP1B1MAPTLMNA
SCHEMBL7191742 0.87 PTPN1 (0.46) TNFRSF1ACYP1A1CYP1B1MAPTLMNA
SCHEMBL7186825 0.85 CTSL (0.61) TNFRSF1ACYP1A1CYP1B1MAPTLMNA
SCHEMBL7186830 0.85 CTSL (0.61) TNFRSF1ACYP1A1CYP1B1MAPTLMNA
SCHEMBL9112769 0.85 TNFRSF1A (0.73) TNFRSF1ACYP1A1CYP1B1MAPTLMNA
SCHEMBL7186659 0.85 TNFRSF1A (0.52) TNFRSF1ACYP1A1CYP1B1MAPTLMNA
SCHEMBL7186661 0.85 TNFRSF1A (0.52) TNFRSF1ACYP1A1CYP1B1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed